Annual Report

CRISPR Therapeutics AG Filed 2024-02-21 Acc 0000950170-24-017571

Documents 1

2025-02-11 10-K Annual Report
2024-02-21 4 General Counsel and Secretary sold 1,913 shares at $79.67 ($152,409)
2024-02-21 4 Chief Executive Officer sold 6,370 shares at $79.67 ($507,498)
2024-02-21 10-K Annual Report
2024-02-21 8-K Results of operations
2024-02-16 4 Chief Executive Officer sold 20,000 shares at an average $80.36 ($1,607,177)
2023-02-21 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading crsp-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…